Zona Pellucida Glycoprotein 3 Antikörper (AA 353-380) (HRP)

Produktnummer ABIN1951651

Produktdetails anti-Zona Pellucida Glycoprotein 3 Antikörper (HRP)

Target: Zona Pellucida Glycoprotein 3 (ZP3)

Bindungsspezifität: AA 353-380

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Zona Pellucida Glycoprotein 3 Antikörper ist konjugiert mit HRP

Applikation: Western Blotting (WB), ELISA

Spezifität: This ZP3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 353-380 amino acids from the C-terminal region of human ZP3.

Aufreinigung: Affinity purified

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Approved: ELISA, WB

Usage: The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS, no preservatives added

Konservierungsmittel: Without preservative

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Haltbarkeit: 6 months

Details zu Zona Pellucida Glycoprotein 3

Target: Zona Pellucida Glycoprotein 3 (ZP3)

Andere Bezeichnung: ZP3 (ZP3 Produkte)

Synonyme: ZP3A antikoerper, ZP3B antikoerper, ZPC antikoerper, Zp-3 antikoerper, zp3.2 antikoerper, Zp-3B antikoerper, zona pellucida glycoprotein 3 antikoerper, zona pellucida sperm-binding protein 3 antikoerper, ZP3 antikoerper, zp3 antikoerper, Zp3 antikoerper

Hintergrund: Name/Gene ID: ZP3

Synonyms: ZP3, Zona pellucida glycoprotein 3B, Zp-3, ZP3-424, ZP3A, ZP3B, ZP3-372, ZPC, Sperm receptor, Zona pellucida glycoprotein 3, Zona pellucida protein C

Gen-ID: 7784

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process